Viviane Yargeau serves as Professor at McGill University. Yargeau also serves as the Chief Technology Officer and Director at Earth Alive Clean Technologies inc. She is a chemical engineer, she serves on various committees including the international management committees of the Advanced Oxidation Processes specialist group of the International Water Association (IWA) and on several journal editorial boards. Her expertise is in chemical and environmental engineering. She is a leader in the control and assessment of environmental pollutants and her research focuses on both fundamental and technological aspects leading to improvement of technologies to mitigate the release of pollutants in the environment. Dr. Yargeau has established strong research collaborations in Canada and internationally as well as industrial collaboration. Her multidisciplinary research program also includes working closely with toxicologists in order to assess the impact of pollutants and their transformation products on the environment and public health.
Industry Expertise (4)
Renewables and Environmental
Areas of Expertise (8)
Contaminants of Emerging Concern
Award, Gerald W. Farnell Teaching Scholar (professional)
Award to recognize teaching excellence and novel initiatives, $13,500
Distinction, Ministère de l'éducation, des loisirs et du sport, Quebec (professional)
Five year of funding to acknowledge quality of teaching, $105,000
Université de Sherbrooke: PhD, Chemical Engineering 2002
Université de Sherbrooke: Master's, Chemical Engineering 1997
Université de Sherbrooke: Bachelor's, Chemical Engineering 1995
- Ordre des ingénieurs du Québec
Media Appearances (3)
Illicit Drugs in Wastewater
6-minute documentary on our research on sewage epidemiology
Pharmaceuticals in the environment
6-minute documentary on our research on the presence of pharmaceuticals water
Drogues illégales dans les eaux usées
Radio Web UQAM radio
Interviewed by Carine Monat-Reliat of L'oeuf ou la poule?
Event Appearances (1)
#FlushGate 100 days later
Canadian Water Network public event Montreal
New soil activator containing ammonium lignosulfonate and uses thereof
Research Grants (6)
Evidencing that improvements to wastewater treatment and use of fate models protect sources of drinking water
Natural Sciences and Engineering Research Council of Canada (NSERC) $175,000
Principal Applicant, Operating grant
Development of a novel ozonation system at pilot scale for wastewater disinfection and removal of contaminants of emerging concern
Natural Sciences and Engineering Research Council of Canada (NSERC) $624,700
Principal Investigator, Operating grant
Conventional and advanced wastewater treatment: Providing secure sources of drinking water by removing contaminants of emerging concern
Natural Sciences and Engineering Research Council of Canada (NSERC) $606,133
Principal Investigator, Operating grant
Application of Bioanalytical Tools for the Rapid Assessment of Residual Biological Activity of Wastewater Using in vitro Cell Based Assays
Ontario Ministry of the Environment $30,000
Principal Applicant, Contract
Endocrine Disrupting Chemicals: Towards Responsible Replacements
Canadian Institutes of Health Research (CIHR) $2000000
Co-applicant, Operating grant Principal Investigator - Barbara Hales McGill University
Wastewater in Small, Rural Communities: Integrated Sewage Lagoon and Ozone Treatment
Natural Sciences and Engineering Research Council of Canada (NSERC) $478800
Co-Investigator, Operating grant Principal investigator - Chris Metcalfe Trent University Partner - Aclarus Ozone Water Systems
The study demonstrate the importance of improving wastewater treatment in order to protect our drinking water sources.
This study emphasizes the need for additional chronic toxicity testing to further evaluate the toxicity of compounds or unknown samples.
This study shows that wastewater-bred epidemiology can provide timely and complementary information on alcohol use and alcohol associated risks in terms of exposure at the community level.
Highlights •One of only a few reports on community use of opioid drugs; first for North America. • Evidence of high oxycodone use and consumption of ketamine is found in selected communities. • Sampling rates for passive samplers are determined for the first time for 7 drugs. • POCIS is useful for monitoring in treated WW, but has limited applicability in untreated WW.